Kolexia
Nogues Catherine
Santé publique
Centre Paoli-Calmettes
Marseille, France
113 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Prédisposition génétique à une maladie Tumeurs de l'ovaire Tumeurs du sein triple-négatives Tumeurs de l'estomac Tumeurs colorectales héréditaires sans polypose Carcinome épithélial de l'ovaire Genetic Risk Score Tumeurs de l'endomètre

Industries

AstraZeneca
1 collaboration(s)
Dernière en 2019
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

LUCID: Study of Families With an Hemopathies Predisposition Related to the DDX41 Gene.
Essai Clinique (Institut Universitaire du Cancer Toulouse Oncopole)   28 février 2024
LIBER: Prevention of Breast Cancer by Letrozole in Post-menopausal Women Carrying a BRCA1/BRCA2 Mutation
Essai Clinique (Unicancer)   20 février 2024
Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation.
Journal of the National Cancer Institute   13 novembre 2023
Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium.
Breast cancer research : BCR   20 juin 2023
Links between gender norms and the intergenerational transmission of health information in parents carrying BRCA1/2 pathogenic variants.
Journal of genetic counseling   06 juin 2023
The Identification of Large Rearrangements Involving Intron 2 of the Gene in Negative and Breast Cancer Susceptibility.
Genes   25 novembre 2022
Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the disease.
European journal of cancer (Oxford, England : 1990)   13 novembre 2022
Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.
American journal of human genetics   30 septembre 2021
821TiP GREAT: A multicentric cohort of advanced ovarian cancer (AOC) treated in real life with prospective collection of clinical data, tumor sample, and biomarkers (tBRCA, HRD) including genomic putative theranostic markers: A GINECO study
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation.
Breast cancer research : BCR   03 août 2021